- ►diabetesjournals.org Y Wang, MCY Ng, WY So, PCY Tong, RCW … - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS— The frequencies of ACE gene I/D polymorphisms were in Hardy-Weinberg
equilibrium. Patients who developed a renal end point (n = 98) had higher
frequencies of DD genotype (19.4 vs. 10.8%, P = 0.018) and D allele (41.3 ... Cited by 22 - Related articles - All 7 versions
HA Ergen, H Hatemi, B Agachan, H Camlica, T … - Experimental and Molecular Medicine, 2004 - kmbase.medric.or.kr Non-insulin dependent diabetes mellitus is often associated with some
complications such as nephropathy, retinopathy and neuropathy. Genes of the
renin angiotensin system are potential candidate genes for diabetic ... Cited by 18 - Related articles - Cached - BL Direct - All 11 versions
WY So, RCW Ma, R Ozaki, PCY Tong, MCY … - Kidney International, 2006 - nature.com Angiotensin-converting enzyme (ACE) insertion(I)/deletion (D) polymorphism may
modify the effect of inhibition of the renin–angiotensin–aldosterone system
(RAAS) on survival and cardiorenal outcomes in type 2, diabetes. A ... Cited by 25 - Related articles - BL Direct - All 5 versions
HC Park, SR Choi, BS Kim, TH Lee, BS Kang, … - Yonsei Medical Journal, 2005 - ymj.or.kr 780 Hyeong Cheon Park, et al. gene has been the most extensively studied among
the candidate genes implicated in the de- velopment and progression of diabetic
nephro- pathy, although conflicting results have been reported to date.9" ... Cited by 7 - Related articles - BL Direct - All 7 versions
S Fradin, B Goulet-Salmon, M Chantepie, F … - Diabetes & metabolism, 2002 - cat.inist.fr Contexte: Le système Rénine Angiotensine est impliqué dans la fonction
rénale et ses polymorphismes peuvent influencer la néphropathie diabétique.
Le polymorphisme ID de l'ECA régule le taux d'ECA tandis que le ... Cited by 23 - Related articles - BL Direct - All 3 versions
- ►nih.gov HH Parving, D de Zeeuw, ME Cooper, G … - J Am Soc Nephrol, 2008 - Am Soc Nephrol ABSTRACT Losartan treatment reduced renal outcomes in proteinuric patients with
type 2 diabetes in the Reduction of Endpoints in NIDDM with the Angiotensin II
Antagonist Losartan (RENAAL) study. It is unknown whether an insertion (I)/ ... Cited by 13 - Related articles - All 6 versions
[CITATION] Role of genetic factors and arterial hypertension in development and progression of diabetic …
